Home > Healthcare > Medical Devices > Therapeutic Devices > Therapeutic Respiratory Devices Market
Therapeutic Respiratory Devices Market Size
Therapeutic Respiratory Devices Market size was worth more than USD 47 billion in 2022 and is poised to exhibit 4.7% CAGR from 2023 to 2032 driven by the rising prevalence of respiratory diseases globally.
In recent years, respiratory diseases have turned to be the major cause of mortality in both developing and underdeveloped nations. There has also been a rapid rise in the number of non-contagious respiratory disorders, such as asthma, COPD, cystic fibrosis, and lung cancer. As per the European Academy of Allergy and Clinical Immunology (EAACI) Global Atlas of Asthma 2022, more than 350 million people worldwide suffer from asthma. Furthermore, the rising levels of air pollution is increasing the burden of lung and respiratory ailments.
| Report Attributes | Details |
|---|---|
| Base Year: | 2022 |
| Market Size in 2022: | USD 47.2 Billion |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 4.7% |
| 2032 Value Projection: | USD 72.8 Billion |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 330 |
| Tables, Charts & Figures: | 625 |
| Segments covered: | Product, Application, End-use, Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Therapeutic respiratory devices play a pivotal role in managing respiratory diseases, by providing much-needed relief and improving the quality of life for patients. These devices encompass a wide range of tools, including inhalers, nebulizers, positive airway pressure machines, and oxygen concentrators. Additionally, the advent of medically advanced respiratory devices has revolutionized the treatment of respiratory diseases for improved respiratory functions and enhanced overall well-being.
COVID-19 Impact
The COVID-19 pandemic proved beneficial to the demand for therapeutic respiratory devices. The increasing spread of the infection by respiratory droplets and the rising impacts on the respiratory system led to the surging adoption of respiratory medical devices. Furthermore, the influx of new product improvements and launches to meet the rising demand boosted the market expansion. For instance, the U.S. FDA granted emergency authorization to use Vesper, a device created by Prisma Health for sustaining up to four patients on a ventilator.
Therapeutic Respiratory Devices Market Trends
The increasing R&D spending on different technical breakthroughs in therapeutic respiratory devices will accelerate the market development. Advanced respiratory devices allow patients to utilize practical and user-friendly gadgets for the treatment of various respiratory disorders. Furthermore, the demand for portable and miniaturized therapeutic ventilators is picking pace as they are quick, affordable, and may be used outdoors without the supervision of doctors.
Therapeutic Respiratory Devices Market Analysis
Therapeutic respiratory devices market size from the inhalers product segment is expected to generate more than USD 40 billion in revenue by the end of 2032. The higher availability of newly developed automated inhalers, including metered-dose inhalers, dry powder inhalers, and soft mist inhalers for aiding the administration of appropriate quantities of drugs to patients has boosted the demand for inhalers.
Based on application, the asthma segment in the therapeutic respiratory devices market share is estimated to record USD 19 billion through 2032. This can be attributed to the rising prevalence of chronic illness affecting children worldwide, including asthma. According to the Asthma and Allergy Foundation of America, around 25 million individuals in the U.S. suffer from asthma, accounting for nearly one in every thirteen people. The rising incidence of asthma worldwide has spurred the demand for inhalers and nebulizers.
North America therapeutic respiratory devices market size is poised to expand at over 3.5% CAGR by 2032. The industry development can be ascribed to the growing frequency of respiratory disorders, higher availability of modern healthcare infrastructure, and the presence of leading market players across the region. Also, the widespread adoption of new technologies among patients along with favorable reimbursement circumstances may augment the industry outlook.
Therapeutic Respiratory Devices Market Share
Some of the major companies operating in the therapeutic respiratory devices market include
- Hill-Rom Services Inc. (Baxter)
- ResMed Inc.
- Drägerwerk AG & Co. KGaA
- Hamilton Medical
- Koninklijke Philips N.V.
- VYAIRE MEDICAL, INC.
- Invacare Corporation
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Breas Medical AB
- ICU Medical
- Medtronic
- Fisher & Paykel Healthcare Limited
- GE Healthcare
Therapeutic Respiratory Devices Industry News
- In September 2022, Aerin Medical Inc., introduced RhinAer Stylus, an FDA-approved noninvasive radiofrequency approach that addresses the causes of chronic rhinitis postnasal drip, runny nose, and nasal congestion.
The therapeutic respiratory devices market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
Market Size, By Product
- Positive airway pressure (PAP) devices
- Continuous positive airway pressure (CPAP) devices
- Auto-titrating positive airway pressure (APAP) devices
- Bi-level positive airway pressure (BiPAP) devices
- Oxygen concentrator
- Fixed oxygen concentrators
- Portable oxygen concentrators
- Ventilators
- Adult ventilators
- Neonatal ventilators
- Inhalers
- Metered dose inhaler (MDI)
- Dry powder inhaler (DPI)
- Soft mist inhaler (SMI)
- Nebulizers
- Compressor-based nebulizers
- Piston-based hand-held nebulizers
- Ultrasonic nebulizers
- Humidifiers
- Heated humidifiers
- Passover humidifiers
- Integrated humidifiers
- Built-in humidifiers
- Standalone humidifiers
- Others
Market Size, By Application
- COPD
- Obstructive sleep apnea
- Asthma
- Respiratory distress syndrome
- Cystic fibrosis
- Others
Market Size, By End-use
- Hospital
- Homecare settings
- Emergency centers
The above information is provided for the following regions and countries:
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Latin America
- Brazil
- Argentina
- Mexico
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Frequently Asked Questions (FAQ) :